尿道成形术后患者报告结局的前瞻性综合评估
本研究前瞻性纳入2012至2018年接受尿道成形术的患者,评估术后6个月患者报告结局。357例完成研究,平均年龄49.7岁,平均狭窄长度4.4 cm,95.9%患者6个月膀胱镜无狭窄复发。
要点
- 排尿功能与泌尿生殖疼痛显著改善,但12.0%报告新发勃起功能障碍。
- 小部分患者报告新发阴茎缩短(6.7%)或弯曲(3.1%),术前应告知。
核心结论
- 尿道成形术改善尿道狭窄相关的排尿功能及泌尿生殖疼痛。
- 多数患者性功能保留,但小部分出现新发勃起功能障碍、阴茎缩短或弯曲,应术前告知。
研究设计与样本
- 前瞻性研究,2012至2018年纳入接受尿道成形术患者,术前及术后6个月评估多个患者报告结局领域。
- 共357例完成研究,平均年龄49.7岁,平均狭窄长度4.4 cm。
主要发现
- 95.9%患者术后6个月膀胱镜无狭窄复发。
- 国际前列腺症状评分(IPSS)从19.3降至6.0(P < .0001),泌尿生活质量从4.7降至1.6(P < .0001)。
- 排尿后滴沥从2.7降至2.5(P = .04),坐位排尿从2.4降至1.9(P < .0001),泌尿生殖疼痛从2.2降至1.6(P < .0001)。
- 平均勃起功能无变化(17.7 vs 17.2;P = .46),但12.0%报告新发勃起功能障碍;射精功能障碍无显著变化(P = .13),但7.1%报告新发射精功能障碍;6.7%和3.1%分别报告困扰的阴茎缩短或弯曲。
临床怎么用
- 术前咨询应告知患者尿道成形术可改善排尿功能及疼痛,多数性功能保留。
- 需告知小部分患者可能新发勃起功能障碍、阴茎缩短或弯曲。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To better define patient-reported outcomes after urethroplasty. While urethroplasty is the most effective treatment for urethral stricture, the majority of outcomes are reported using surgeon-defined endpoints. METHODS: Patients were enrolled in a prospective study evaluating patient-reported outcomes after urethroplasty from 2012 to 2018. A number of domains were assessed preoperatively and 6 months postoperatively using both validated and nonvalidated measures including satisfaction, voiding function, urinary quality of life, erectile/ejaculatory function, penile appearance/curvature, and genitourinary pain. RESULTS: Of 357 patients completing the study, mean age was 49.7 years with mean stricture length of 4.4 cm. Total 95.9% of patients were stricture-free on 6-month cystoscopy. Eighty percent of patients reported being satisfied with surgery, while 7.3% of patients were unsatisfied. Voiding function was globally improved after urethroplasty including International Prostate Symptom Score (19.3 vs 6.0; P < .0001), urinary quality of life (4.7 vs 1.6; P < .0001), postvoid dribbling (2.7 vs 2.5; P = .04), and sitting to void (2.4 vs 1.9; P < .0001). Additionally, genitourinary pain improved postoperatively (2.2 vs 1.6; P < .0001). Mean erectile function remained unchanged (17.7 vs 17.2; P = .46) but 12.0% of patients reported new onset erectile dysfunction. Reported ejaculatory dysfunction did not change significantly postoperatively (P = .13) but 7.1% of patients reported new ejaculatory dysfunction. Total 6.7% and 3.1% of patients complained of bothersome loss of penile length or curvature, respectively. CONCLUSION: Urethroplasty improves voiding function and genitourinary pain associated with urethral stricture. While sexual function is preserved for the majority of patients, a small proportion of patients describe new onset erectile dysfunction, penile shortening or curvature and should be counselled accordingly.
引用
- Redmond E, Bekkema J, Rourke K, et al. Comprehensive Prospective Assessment of Patient-reported Outcomes Following Urethroplasty. Urology. 2020. PMID: 32283167. doi:10.1016/j.urology.2020.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。